Infliximab 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F4F1H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,219
Award facts
- Contract value 100% obligated
- $10,219.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,219.18 to AmerisourceBergen Drug Corp for the supply of Infliximab 100 mg vials, with an ultimate completion date of January 16, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor supporting federal military and healthcare systems through its extensive contract portfolio with the DLA. This delivery order falls under the company's $999,999,999.00 prime IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and enables the supply of a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs globally. Infliximab, a biologic medication used to treat inflammatory conditions, represents one of the specialized pharmaceuticals within AmerisourceBergen's broad medical supply capabilities serving the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4F1H?
SPE2DR26F4F1H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F4F1H worth?
The government has obligated $10,219 on SPE2DR26F4F1H.
Is contract SPE2DR26F4F1H an order under another contract?
Yes. SPE2DR26F4F1H is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F1H competed?
The extent of competition for SPE2DR26F4F1H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award